000 | 01119 a2200325 4500 | ||
---|---|---|---|
005 | 20250513213428.0 | ||
264 | 0 | _c20001020 | |
008 | 200010s 0 0 eng d | ||
022 | _a0001-6314 | ||
024 | 7 |
_a10.1034/j.1600-0404.2000.0006a.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNicholson, B | |
245 | 0 | 0 |
_aGabapentin use in neuropathic pain syndromes. _h[electronic resource] |
260 |
_bActa neurologica Scandinavica _cJun 2000 |
||
300 |
_a359-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAcetates _xtherapeutic use |
650 | 0 | 4 | _aAmines |
650 | 0 | 4 |
_aAnalgesics _xtherapeutic use |
650 | 0 | 4 | _aCyclohexanecarboxylic Acids |
650 | 0 | 4 | _aGabapentin |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPain _xdrug therapy |
650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xdrug therapy |
650 | 0 | 4 | _aProto-Oncogene Mas |
650 | 0 | 4 | _aSyndrome |
650 | 0 | 4 | _agamma-Aminobutyric Acid |
773 | 0 |
_tActa neurologica Scandinavica _gvol. 101 _gno. 6 _gp. 359-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1034/j.1600-0404.2000.0006a.x _zAvailable from publisher's website |
999 |
_c10827807 _d10827807 |